
	GenMark Diagnostics is a leading provider of automated multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark&#39;s proprietary eSensor&reg; detection technology GenMark&#39;s eSensor&reg; XT-8 system is designed to support a broad range of molecular diagnostic tests with a compact easy-to-use workstation and self-contained disposable test cartridges. GenMark currently markets four tests that are FDA cleared for IVD use: Cystic Fibrosis Genotyping Test Respiratory Viral Panel Thrombophilia Risk Test and Warfarin Sensitivity Test. A number of other tests including HCV Genotyping 2C19 Genotyping and 3A4/3A5 Genotyping are available for research use only.
